200 related articles for article (PubMed ID: 11073268)
1. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
Ferreira MA
Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
[No Abstract] [Full Text] [Related]
2. Biological markers in the diagnosis of the different forms of renal osteodystrophy.
Ferreira A; Drüeke TB
Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481
[TBL] [Abstract][Full Text] [Related]
3. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
6. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Fournier A; Ghitu S; Bako G; Ben Amar L; Oprisiu R; Hottelart C; Cohen Solal ME
Nephrol Dial Transplant; 1999 Nov; 14(11):2772-4. PubMed ID: 10534531
[No Abstract] [Full Text] [Related]
7. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy.
Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J
Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341
[No Abstract] [Full Text] [Related]
8. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need?
Ferreira A
Nephrol Dial Transplant; 1998; 13 Suppl 3():29-32. PubMed ID: 9568817
[No Abstract] [Full Text] [Related]
10. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
11. Bone biopsy in chronic kidney disease: still an option?
Drueke TB
J Bras Nefrol; 2020 May; 42(2):130-132. PubMed ID: 32459283
[No Abstract] [Full Text] [Related]
12. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
[TBL] [Abstract][Full Text] [Related]
13. Commentary.
Hruska K
Clin Chem; 2009 Sep; 55(9):1740-1. PubMed ID: 19717660
[No Abstract] [Full Text] [Related]
14. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
15. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.
Bacchetta J; Wesseling-Perry K; Kuizon B; Pereira RC; Gales B; Wang HJ; Elashoff R; Salusky IB
Clin J Am Soc Nephrol; 2013 May; 8(5):824-32. PubMed ID: 23559676
[TBL] [Abstract][Full Text] [Related]
16. [A pathological analysis of 51 cases of renal osteodystrophy].
Yu YF; Hu YX; Zhu P
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
[TBL] [Abstract][Full Text] [Related]
17. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and monitoring of renal osteodystrophy.
Roe S; Cassidy MJ
Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):675-81. PubMed ID: 11128431
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
Douthat WG; Garay G; de Arteaga J; Fernández Martín JL; Cannata Andía JB; Massari PU
Nefrologia; 2003; 23 Suppl 2():47-51. PubMed ID: 12778854
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
